EFEMP2 and endometrial carcinoma: However, in human endometrial carcinoma, the fibulin-4 protein expression level is inversely correlated with the malignant phenotype, and fibulin-4 demonstrates inhibitory effects in endometrial carcinoma proliferation, invasion, metastasis, and EMT through the Wnt/β-catenin pathway [103].